Research Dynamics
28
Feb

2017

CPH – FY2016 results

On the road to profitable growth

– 2016: moderate revenue growth with positive EBIT
– Efforts should start yielding results
– An encouraging year ahead
– Valuation: market is yet to price in the operational improvements

18
Oct

2016

CPH – Company Update

Site for new European manufacturing unit acquired

– Land acquisition to diversify manufacturing base
– Sale of Uetikon facility
– In line with the Chemistry segment’s strategy
– Valuation and conclusion

25
Jul

2016

CPH – 1H 2016 earnings update

On road to recovery

  • Strong 1H 2016 results: Posting an operating profit
  • Segmental performance
  • Guidance
  • Changes to our forecast
  • Valuation and conclusion
22
Mar

2016

CPH – Company Update

Sale of Uetikon site to Canton of Zurich
–  Successful conclusion of lengthy negotiations
–  Implications for CPH’s Chemistry division
–  Strategically sensible move
–  Valuation

1
Mar

2016

CPH – FY2015 results

Currency hits 2015 results, recovery seen in 2016
– 2015: Volumes increase, but strong currency depresses earnings
– Strategically important 2016: Entry into China market
– Performance likely to improve
– Valuation

23
Jul

2015

CPH – 1H 2015 earnings update

Currency headwind shadows growth

  • CHF/EUR floor abolishment weighs on 1H 2015 result
  • Segmental performance
  • Guidance
  • Changes to our forecasts
  • Valuation and conclusion
3
Mar

2015

CPH – FY2014 results

Gratifying 2014 results, challenging outlook

– FY2014 numbers in line with guidance
– Execution of plans yield solid results
– A shift to high-growth markets to reduce dependency on Europe
– De-peg of CHF vs. EUR to be a near-term headwind
– Attractive entry point at current valuations

3
Mar

2015

CPH – 2014 Ergebnisse und Update

Erfreuliche Ergebnisse 2014, Ausblick herausfordernd

– Ergebnisse für das Geschäftsjahr 2014 im Einklang mit Guidance
– Projekt-Umsetzung führt zu soliden Ergebnissen
– Expansion in Wachstumsmärkte reduziert Abhängigkeit von Europa
– Aufhebung der Mindestgrenze zum EUR als kurzfristiger Gegenwind
– Attraktiver Einstiegszeitpunk bei aktueller Bewertung

29
Sep

2014

CPH – Initiation of Coverage

Recovering its footing

– Exposure to high-growth markets to bolster revenues
– Investments in technology to boost margin expansion over long-term
– Healthy H1 2014; positive outlook over the medium-term
– Current valuation level offers an entry opportunity

29
Sep

2014

CPH – Aufnahme der Coverage

Rückkehr zu Stabilität und Wachstum

– Fokus auf schnell wachsende Märkte
– Investitionen in Technologie zur langfristigen Verbesserung der Margen
– Robustes 1. Halbjahr 2014; mittelfristig positiver Ausblick
– Derzeitige Bewertung bietet Einstiegsmöglichkeiten